First Time Loading...

ChemoCentryx Inc
NASDAQ:CCXI

Watchlist Manager
ChemoCentryx Inc Logo
ChemoCentryx Inc
NASDAQ:CCXI
Watchlist
Price: 51.99 USD
Updated: May 21, 2024

ChemoCentryx Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ChemoCentryx Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
ChemoCentryx Inc
NASDAQ:CCXI
Cash from Operating Activities
-$53.5m
CAGR 3-Years
7%
CAGR 5-Years
-62%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$22.7B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
15%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$8.5B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.1B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
$3.9B
CAGR 3-Years
5%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.7B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
24%

See Also

What is ChemoCentryx Inc's Cash from Operating Activities?
Cash from Operating Activities
-53.5m USD

Based on the financial report for Jun 30, 2022, ChemoCentryx Inc's Cash from Operating Activities amounts to -53.5m USD.

What is ChemoCentryx Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-62%

Over the last year, the Cash from Operating Activities growth was 28%. The average annual Cash from Operating Activities growth rates for ChemoCentryx Inc have been 7% over the past three years , -62% over the past five years .